Leading a metabolic health revolution in Asia

Governments and health systems across Asia aspire to shift toward proactive, preventive care. Yet historically, prevention budgets and policies haven’t matched the rhetoric, leaving reactive treatment models dominant.

Today, a new era of change is emerging — from public health initiatives and infrastructure planning to pharmaceutical and wearable-driven innovation — signaling that prevention and treatment are on track to converge for better outcomes. Can Asia become the first region to truly integrate prevention and innovation at scale?

In this episode, host Debbi Cheong is joined by Hemant Ahlawat, Senior Partner at McKinsey & Company in Zurich, and Panco Georgiev, Senior Partner in Dubai.

See www.mckinsey.com/privacy-policy for privacy information